Trials / Completed
CompletedNCT02475109
Study of Topical Ocular PAN-90806 in PDR
A Phase 1 Open-Label, Single-Center Study to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Proliferative Diabetic Retinopathy (PDR)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- PanOptica, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the safety and tolerability of topical ocular PAN-90806 in patients with proliferative diabetic retinopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PAN-90806 Ophthalmic Solution |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2016-05-01
- Completion
- 2016-07-01
- First posted
- 2015-06-18
- Last updated
- 2016-09-28
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02475109. Inclusion in this directory is not an endorsement.